Kingworld Medicines Group Limited

HKEX:1110.HK

0.6 (HKD) • At close May 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024202320222021202020192018201720162015201420132012201120102009
Revenue 1,061.0821,078.659957.701847.386745.383977.9281,078.8431,031.4881,053.527713.548660.323554.763705.519685.562638.046556.417
Cost of Revenue 790.636797.994680.074583.788465.229710.525767.346708.317729.955486.771504.013423.584541.674524.73497.899435.764
Gross Profit 270.446280.665277.627263.598280.154267.403311.497323.171323.572226.777156.31131.179163.845160.832140.147120.653
Gross Profit Ratio 0.2550.260.290.3110.3760.2730.2890.3130.3070.3180.2370.2360.2320.2350.220.217
Reseach & Development Expenses 17.59318.8415.51913.40613.25715.07213.87212.8287.8137.415000000
General & Administrative Expenses 90.657119.532104.57396.644112.559107.44396.35689.31375.54369.27345.8941.51236.83237.69525.47320.441
Selling & Marketing Expenses 98.839102.762100.45299.514132.95112.283155.073162.105149.129101.47387.73470.28678.37770.964.86158.378
SG&A 192.606222.294205.025196.158245.509219.726251.429251.418224.672170.746133.624111.798115.209108.59590.33478.819
Other Expenses -29.457-57.2759.4538.510.81512.38117.7678.6642.7422.742.3022.611.0371.653-16.561-14.529
Operating Expenses 180.742183.859214.478204.668246.324232.107265.966269.167227.142176.334109.08104.84108.847106.43473.77364.29
Operating Income 89.70496.80672.23572.22573.64976.74468.84695.70395.7249.15349.30156.73465.87678.50666.37456.363
Operating Income Ratio 0.0850.090.0750.0850.0990.0780.0640.0930.0910.0690.0750.1020.0930.1150.1040.101
Total Other Income Expenses Net 5.815-2.92-4.651-2.791-2.758-6.9351.534-12.376-6.6762.169-0.6346.485.546-4.69-8.032-9.61
Income Before Tax 95.51993.88667.58469.43470.89169.80970.3883.32789.04451.32248.66763.21463.25773.81658.34246.753
Income Before Tax Ratio 0.090.0870.0710.0820.0950.0710.0650.0810.0850.0720.0740.1140.090.1080.0910.084
Income Tax Expense 21.05332.29224.04218.22320.00219.53818.62116.79521.63811.93510.80216.03714.72222.78515.4799.509
Net Income 41.55738.09643.54251.21150.88943.42741.00551.0646.96631.20537.86547.17748.53551.03142.86337.244
Net Income Ratio 0.0390.0350.0450.060.0680.0440.0380.050.0450.0440.0570.0850.0690.0740.0670.067
EPS 0.0720.0640.0720.0840.0830.070.0660.0820.0730.0470.0610.0760.0780.0820.0920.083
EPS Diluted 0.0720.0640.070.0820.0830.070.0660.0820.0730.0470.0610.0760.0780.0820.0920.083
EBITDA 100.459125.48118.068116120.589121.61116.184135.312125.50974.25951.25630.46865.26179.93767.50257.325
EBITDA Ratio 0.0950.1160.1230.1370.1620.1240.1080.1310.1190.1040.0780.0550.0930.1170.1060.103